v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
Current Assets:      
Cash $ 38,887 $ 204,725 $ 3,353,732
Accounts receivable 15,624 5,110 999
Other receivable 302,500 302,500 302,500
Inventory 24,430 24,430 24,430
Prepaid expenses 66,818 170,257 206,784
Deferred offering costs 460,915  
Other current assets 447,329 76,166
Total Current Assets 1,356,503 783,188 3,888,445
Property and Equipment, net of depreciation 1,974,467 2,022,043 2,094,536
Patents, net of amortization 1,995,774 1,991,623 1,972,830
Total Assets 5,326,744 4,796,854 7,955,811
Current Liabilities:      
Accounts payable and accrued expenses 5,553,222 3,509,936 2,135,586
Income taxes payable   6,369
Excise tax payable 1,060,321 964,463 909,871
Derivative liabilities 4,211,250 4,772,600 25,272,650
Convertible notes   527,500
Short-term notes payable 2,607,666 2,647,556 1,917,962
Total Liabilities 13,595,332 11,982,428 30,857,811
Commitments and contingencies (Note 6)  
Stockholders’ Deficit:      
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Common stock, value 774 746 13,169
Additional paid-in capital 159,453,519 159,027,646 101,998,956
Stock subscription receivable (2,919,674) (2,841,427) (2,545,586)
Accumulated deficit (164,803,207) (163,372,539) (122,368,539)
Total Stockholders’ Deficit (8,268,588) (7,185,574) (22,902,000)
Total Liabilities and Stockholders’ Deficit 5,326,744 4,796,854 7,955,811
Related Party      
Current Liabilities:      
Due to related party $ 162,873 $ 87,873 $ 87,873